Specifically, astrocytic injury was observed in the acute phase of COVID-19, as shown by high plasma levels of glial fibrillary acidic protein (GFAP), with more pronounced findings in hospitalized patients (Kanberg et al., 2020). The gene discussed is GFAP; the disease is COVID-19.